Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-29 @ 1:45 AM
Study NCT ID:
NCT03930732
Status:
COMPLETED
Last Update Posted:
2024-02-28
First Post:
2019-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-26
First Submit QC Date:
None
Study First Post Date:
2019-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-30
Results First Submit QC Date:
None
Results First Post Date:
2024-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-30
Last Update Post Date:
2024-02-28
Last Update Post Date Type:
ACTUAL